ACADIA Pharmaceuticals, Inc. (ACAD)
18.14
-0.23
(-1.25%)
USD |
NASDAQ |
Nov 12, 16:00
18.12
-0.02
(-0.08%)
After-Hours: 20:00
ACADIA Pharmaceuticals Debt to Equity Ratio : 0.0518 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0518 |
| June 30, 2026 | 0.0565 |
| March 31, 2026 | 0.0407 |
| December 31, 2025 | 0.0425 |
| September 30, 2025 | 0.0598 |
| June 30, 2025 | 0.0685 |
| March 31, 2025 | 0.0732 |
| December 31, 2024 | 0.071 |
| September 30, 2024 | 0.0855 |
| June 30, 2024 | 0.1116 |
| March 31, 2024 | 0.1285 |
| December 31, 2023 | 0.1325 |
| September 30, 2023 | 0.1578 |
| June 30, 2023 | 0.1487 |
| March 31, 2023 | 0.162 |
| December 31, 2022 | 0.1548 |
| September 30, 2022 | 0.148 |
| June 30, 2022 | 0.1465 |
| March 31, 2022 | 0.1448 |
| December 31, 2021 | 0.1191 |
| September 30, 2021 | 0.1161 |
| June 30, 2021 | 0.118 |
| March 31, 2021 | 0.1146 |
| December 31, 2020 | 0.079 |
| September 30, 2020 | 0.0751 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.0126 |
| March 31, 2020 | 0.0141 |
| December 31, 2019 | 0.014 |
| September 30, 2019 | 0.0149 |
| June 30, 2019 | 0.0287 |
| March 31, 2019 | 0.0268 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ionis Pharmaceuticals, Inc. | 5.520 |
| Arcturus Therapeutics Holdings, Inc. | 0.1296 |
| ADMA Biologics, Inc. | 0.4625 |
| Immunic, Inc. | 0.0044 |
| Viking Therapeutics, Inc. | 0.4327 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.794B |
| Total Liabilities (Quarterly) | 406.66M |
| Shareholders Equity (Quarterly) | 1.387B |
| Current Ratio | 3.818 |
| Net Debt Paydown Yield | -0.09% |